Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NUFARM LIMITED Director's Dealing 2016

Oct 5, 2016

65453_rns_2016-10-05_f2ad34da-c75c-4351-8ca3-1d696648cd5a.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [595 x 210] intentionally omitted <==

Please find attached an updated Appendix 3Y for Dr WB Goodfellow.

Please note there has been no change to the number of Nufarm shares in which Dr Goodfellow has an interest. The Appendix 3Y reflects a reorganization of Dr Goodfellow’s indirect interests.

Page 1 of 1

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity NUFARM LIMITED ABN 37 091 323 312

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director WILLIAM BRUCE GOODFELLOW
Date of last notice 9/5/2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
WB Goodfellow and EW Preston as the
Trustees of the 531 Trust and Henry Berry
Corporation Limited
Date of change 3/10/16
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change Direct:
112,891 Fully Paid Ordinary Shares
Indirect:
Pacific Custodians Pty Ltd – 31,585 Fully
Paid Ordinary Shares
MA Goodfellow – 13,000 Fully Paid
Ordinary Shares and 100 NSS
St Kentigern Trust – 430,434 Fully Paid
Ordinary Shares and 19,727 NSS
Sulkem Company Ltd – 128,110 Fully Paid
Ordinary Shares
Auckland Medical Research Foundation –
26,558 NSS
Trustees of The Goodfellow Foundation –
33,854 Fully Paid Ordinary
Shares and 1,338 NSS
WB Goodfellow and Edgar William
Preston as Trustees of the 531
Trust – 400,861 Fully Paid
Ordinary Shares
Henry Berry Corporation Limited –
20,000Fully Paid Ordinary Shares
700 NSS
Class Ordinary Shares
Number acquired Henry Berry Corporation Limited – 400,861
Ordinary Shares
Number disposed WB Goodfellow and EW Preston as
Trustees of the 531 Trust – 400,861
Ordinary Shares
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
Nil
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change Direct:
112,891 Fully Paid Ordinary Shares
Indirect:
Pacific Custodians Pty Ltd – 31,585 Fully
Paid Ordinary Shares
MA Goodfellow – 13,000 Fully Paid
Ordinary Shares and 100 NSS
St Kentigern Trust – 430,434 Fully Paid
Ordinary Shares and 19,727 NSS
Sulkem Company Ltd – 128,110 Fully Paid
Ordinary Shares
Auckland Medical Research Foundation –
26,558 NSS
Trustees of The Goodfellow Foundation –
33,854 Fully Paid Ordinary
Shares and 1,338 NSS
Henry Berry Corporation Limited – 420,861
Fully Paid Ordinary Shares
700 NSS
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Off market trades

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts Not Applicable detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

  • See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011